Abstract
No public abstract is available from the verified source records.
Maryam Bemanalizadeh, Shiva Moein, Asad Kazemi
Abstract
Authors
Institutions
No local reference links have been materialized yet.
No local citing links have been materialized yet.
High-dose AAV gene therapy deaths
10.1038/s41587-020-0642-9 · 2020
Modeling Alzheimer’s Disease in Caenorhabditis elegans
10.3390/biomedicines10020288 · 2022
Alzheimer’s-associated PLCγ2 is a signaling node required for both TREM2 function and the inflammatory response in human microglia
10.1038/s41593-020-0650-6 · 2020
ApolipoproteinE4 Causes Age- and Tau-Dependent Impairment of GABAergic Interneurons, Leading to Learning and Memory Deficits in Mice
10.1523/jneurosci.4040-10.2010 · 2010
Impairment of cholinergic neurotransmission in adult and aged transgenic Tg2576 mouse brain expressing the Swedish mutation of human β-amyloid precursor protein
10.1016/s0006-8993(02)03262-6 · 2002
Gene therapy clinical trials, where do we go? An overview
10.1016/j.biopha.2022.113324 · 2022
Functionalized nanoparticles for brain targeted BDNF gene therapy to rescue Alzheimer’s disease pathology in transgenic mouse model
10.1016/j.ijbiomac.2022.03.203 · 2022
Probing the Biology of Alzheimer’s Disease in Mice
10.1016/j.neuron.2010.04.031 · 2010
Current and Future Treatments in Alzheimer’s Disease
10.1055/s-0039-1678581 · 2019
Provenance
crossref
Confidence 100%
ror
Confidence 99%
openalex
Confidence 95%
datacite
Confidence 0%
The role of APOE in transgenic mouse models of AD
10.1016/j.neulet.2019.134285 · 2019
A novel human tau knock-in mouse model reveals interaction of Abeta and human tau under progressing cerebral amyloidosis in 5xFAD mice
10.1186/s13195-022-01144-y · 2023
miRNA-31 Improves Cognition and Abolishes Amyloid-β Pathology by Targeting APP and BACE1 in an Animal Model of Alzheimer’s Disease
10.1016/j.omtn.2020.01.010 · 2020
Genetics of Alzheimer disease
10.1177/0891988710383571 · 2010
Temporal and regional progression of Alzheimer’s disease‐like pathology in 3xTg‐AD mice
10.1111/acel.12873 · 2019
Transport pathways for clearance of human Alzheimer’s amyloid β-peptide and apolipoproteins E and J in the mouse central nervous system
10.1038/sj.jcbfm.9600419 · 2007
New insights into the genetic etiology of Alzheimer’s disease and related dementias
10.1038/s41588-022-01024-z · 2022
Reducing human Apolipoprotein E levels attenuates age-dependent Aβ accumulation in mutant human amyloid precursor protein transgenic mice
10.1523/jneurosci.0033-12.2012 · 2012
Intraneuronal Aβ causes the onset of early Alzheimer’s disease-related cognitive deficits in transgenic mice
10.1016/j.neuron.2005.01.040 · 2005
Therapeutic potential of CERE-110 (AAV2-NGF): targeted, stable, and sustained NGF delivery and trophic activity on rodent basal forebrain cholinergic neurons
10.1016/j.expneurol.2008.03.004 · 2008
APOE4 impairs myelination via cholesterol dysregulation in oligodendrocytes
10.1038/s41586-022-05439-w · 2022
APOE2 mitigates disease-related phenotypes in an isogenic hiPSC-based model of Alzheimer’s disease
10.1038/s41380-021-01076-3 · 2021
Epigenetic editing of the Dlg4/PSD95 gene improves cognition in aged and Alzheimer’s disease mice
10.1093/brain/awx272 · 2017
The Relationship between the Aberrant Long Non-Coding RNA-Mediated Competitive Endogenous RNA Network and Alzheimer’s Disease Pathogenesis
10.3390/ijms23158497 · 2022
TREM2 regulates microglial cell activation in response to demyelination in vivo
10.1007/s00401-015-1388-1 · 2015
Selective estrogen receptor modulators differentially regulate Alzheimer-like changes in female 3xTg-AD mice
10.1210/en.2007-1346 · 2008
Adeno-associated viral (AAV) serotype 5 vector mediated gene delivery of endothelin-converting enzyme reduces Aβ deposits in APP + PS1 transgenic mice
10.1038/mt.2008.148 · 2008
Postmortem analysis in a clinical trial of AAV2-NGF gene therapy for Alzheimer’s disease identifies a need for improved vector delivery
10.1089/hum.2019.367 · 2020
Advances in epigenetics link genetics to the environment and disease
10.1038/s41586-019-1411-0 · 2019
A mouse model of Alzheimer’s disease displays increased susceptibility to kindling and seizure-associated death
10.1111/epi.12993 · 2015
Intranasal interferon beta improves memory and modulates inflammatory responses in a mutant APP-overexpressing rat model of Alzheimer’s disease
10.1016/j.brainresbull.2019.06.015 · 2019
Somatic gene transfer of NGF to the aged brain: behavioral and morphological amelioration
10.1523/jneurosci.15-04-02819.1995 · 1995
Transfer of three transcription factors via a lentiviral vector ameliorates spatial learning and memory impairment in a mouse model of Alzheimer’s disease
10.1016/j.gene.2016.04.032 · 2016
Early-onset Amyloid Deposition and Cognitive Deficits in Transgenic Mice Expressing a Double Mutant Form of Amyloid Precursor Protein 695
10.1074/jbc.m100710200 · 2001
N-Acetyl Aspartate: a Marker for Neuronal Loss or Mitochondrial Dysfunction
10.1159/000017321 · 1998
Sleep-Wake Cycle Dysfunction in the TgCRND8 Mouse Model of Alzheimer’s Disease: from Early to Advanced Pathological Stages
10.1371/journal.pone.0130177 · 2015
Memory recovery through gene therapy with a single chain antibody fragment selective for Aβ oligomers in a model of Alzheimer’s disease in rats
10.17981/jacn.4.1.2023.2 · 2023
APOE and the regulation of microglial nitric oxide production: a link between genetic risk and oxidative stress
10.1016/s0197-4580(02)00016-7 · 2002
Nontropic actions of neurotrophins: subcortical nerve growth factor gene delivery reverses age-related degeneration of primate cortical cholinergic innervation
10.1073/pnas.98.4.1941 · 2001
Distribution of brain-derived neurotrophic factor (BDNF) protein and mRNA in the normal adult rat CNS: evidence for anterograde axonal transport
10.1523/jneurosci.17-07-02295.1997 · 1997
Severe amygdala dysfunction in a MAPT transgenic mouse model of frontotemporal dementia
10.1016/j.neurobiolaging.2013.12.023 · 2014
Phospholipid dysregulation contributes to apoe4-associated cognitive deficits in Alzheimer’s disease pathogenesis
10.1073/pnas.1510011112 · doi-reference
REM sleep promotes experience-dependent dendritic spine elimination in the mouse cortex
10.1038/s41467-020-18592-5 · doi-reference
Updates on mouse models of Alzheimer’s disease
10.1186/s13024-024-00712-0 · doi-reference
Selective deletion of apolipoprotein E in astrocytes ameliorates the spatial learning and memory deficits in Alzheimer’s disease (APP/PS1) mice by inhibiting TGF-β/Smad2/STAT3 signaling
10.1016/j.neurobiolaging.2017.03.002 · doi-reference
Intracerebral adeno-associated virus gene delivery of apolipoproteinE2markedly reduces brain amyloid pathology in Alzheimer’s disease mouse models
10.1016/j.neurobiolaging.2016.04.020 · doi-reference
Effects of small interfering RNA targeting sphingosine kinase-1 gene on the animal model of Alzheimer’s disease
10.1007/s11596-013-1136-5 · doi-reference
Interaction between Aβ and Tau in the Pathogenesis of Alzheimer’s Disease
10.7150/ijbs.57078 · doi-reference
The microtubule-stabilizing agent, epothilone D, reduces axonal dysfunction, neurotoxicity, cognitive deficits, and Alzheimer-like pathology in an interventional study with aged tau transgenic mice
10.1523/jneurosci.4922-11.2012 · doi-reference
Lentiviral vector–mediated overexpression of Klotho in the brain improves Alzheimer’s disease–like pathology and cognitive deficits in mice
10.1016/j.neurobiolaging.2019.02.003 · doi-reference
Sex difference in pathology and memory decline in rTg4510 mouse model of tauopathy
10.1016/j.neurobiolaging.2009.04.006 · doi-reference
10.1001/jamaneurol.2014.3049
10.1001/jamaneurol.2014.3049 · doi-reference
DNA methylation alterations in Alzheimer’s disease
10.1093/eep/dvx008 · doi-reference
Expression of brain-derived neurotrophic factor protein in the adult rat central nervous system
10.1016/s0306-4522(96)00613-6 · doi-reference
Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies
10.1038/s41582-019-0228-7 · doi-reference
Reduction of glucose metabolism in olfactory bulb is an earlier Alzheimer’s disease-related biomarker in 5XFAD mice
10.4103/0366-6999.162507 · doi-reference
Novel App knock-in mouse model shows key features of amyloid pathology and reveals profound metabolic dysregulation of microglia
10.1186/s13024-022-00547-7 · doi-reference
The effects of rAAV2-mediated NGF gene delivery in adult and aged rats
10.1016/j.ymthe.2003.11.010 · doi-reference
Dystrophic neurites in TgCRND8 and Tg2576 mice mimic human pathological brain aging
10.1016/j.neurobiolaging.2007.09.003 · doi-reference
Sleep and circadian abnormalities in a transgenic mouse model of Alzheimer’s disease: a role for cholinergic transmission
10.1016/j.neuroscience.2004.11.018 · doi-reference
Alzheimer’s Disease and Senile Dementia: loss of Neurons in the Basal Forebrain
10.1126/science.7058341 · doi-reference
Alzheimer’s disease and down syndrome rodent models exhibit audiogenic seizures
10.3233/jad-2010-100087 · doi-reference
Intracranial injection of PEG-PEI/ROCK II-siRNA improves cognitive impairment in a mouse model of Alzheimer’s disease
10.3109/00207454.2013.877014 · doi-reference
Alterations in immunological and neurological gene expression patterns in Alzheimer’s disease tissues
10.1016/j.yexcr.2006.10.028 · doi-reference
An isogenic panel of App knock-in mouse models: profiling β-secretase inhibition and endosomal abnormalities
10.1126/sciadv.abm6155 · doi-reference
Intramuscular delivery of a single chain antibody gene prevents brain Aβ deposition and cognitive impairment in a mouse model of Alzheimer’s disease
10.1016/j.bbi.2010.05.010 · doi-reference
TREM2 lipid sensing sustains the microglial response in an Alzheimer’s disease model
10.1016/j.cell.2015.01.049 · doi-reference
Intramuscular delivery of p75NTR ectodomain by an AAV vector attenuates cognitive deficits and Alzheimer’s disease-like pathologies in APP/PS1 transgenic mice
10.1111/jnc.13616 · doi-reference
Precise gene delivery systems with detachable albumin shell remodeling dysfunctional microglia by TREM2 for treatment of Alzheimer’s disease
10.1016/j.biomaterials.2021.121360 · doi-reference
Ultrasound Combined With Microbubbles Loading BDNF Retrovirus to Open BloodBrain Barrier for Treatment of Alzheimer’s Disease
10.3389/fphar.2021.615104 · doi-reference
STAT3 ameliorates cognitive deficits via regulation of NMDAR expression in an Alzheimer’s disease animal model
10.7150/thno.56541 · doi-reference
Presenilins: members of the γ-Secretase Quartets, But Part-Time Soloists Too
10.1152/physiol.00009.2008 · doi-reference
Episodic memory deficits are not related to altered glutamatergic synaptic transmission and plasticity in the CA1 hippocampus of the APPswe/PS1ΔE9-deleted transgenic mice model of β-amyloidosis
10.1016/j.neurobiolaging.2008.08.005 · doi-reference
Age-dependent hippocampal proteomics in the app/ps1 Alzheimer mouse model: a comparative analysis with classical swath/dia and directdia approaches
10.3390/cells10071588 · doi-reference
TREM2 Maintains Microglial Metabolic Fitness in Alzheimer’s Disease
10.1016/j.cell.2017.07.023 · doi-reference
Nerve growth factor gene therapy activation of neuronal responses in Alzheimer disease
10.1001/jamaneurol.2015.1807 · doi-reference
A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease
10.1038/nm1239 · doi-reference
Targeted intraparenchymal delivery of human NGF by gene transfer to the primate basal forebrain for 3 months does not accelerate β-amyloid plaque deposition
10.1006/exnr.1998.6956 · doi-reference
Cutting edge: TREM-2 attenuates macrophage activation
10.4049/jimmunol.177.6.3520 · doi-reference
Circadian changes in Alzheimer’s disease: neurobiology, clinical problems, and therapeutic opportunities
10.1016/b978-0-12-819975-6.00018-2 · doi-reference
Amyloid precursor protein trafficking, processing, and function
10.1074/jbc.r800019200 · doi-reference